Who is sponsoring NCT06070402?

NCT06070402 is sponsored by University of Valencia.

What drugs are being tested in NCT06070402?

Interventions in NCT06070402: DIAL, a voice-controlled virtual assistant.

What condition does NCT06070402 study?

NCT06070402 studies Depression, Loneliness, Anxiety, Quality of Life.

Is NCT06070402 still recruiting?

NCT06070402 is currently status unknown. Last updated 6 October 2023.

Last reviewed 2023-10-06 · How we verify

NCT06070402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of a Voice Assistant to Improve Mental Health in Older People

Status unknown NA Last updated 6 October 2023

What this trial tests

NA trial testing DIAL, a voice-controlled virtual assistant in Depression in 80 participants. Status unknown.

Timeline

15 October 2023

Primary endpoint
15 November 2023

15 November 2023

Quick facts

Lead sponsor	University of Valencia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	15 October 2023
Primary completion	15 November 2023
Estimated completion	15 November 2023

Drugs / interventions tested

DIAL, a voice-controlled virtual assistant

Conditions studied

Depression — all drugs for Depression →
Loneliness — all drugs for Loneliness →
Anxiety — all drugs for Anxiety →
Quality of Life — all drugs for Quality of Life →

Sponsor

University of Valencia

Who can join

65 and older, any sex, with Depression or Loneliness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to evaluate the effectiveness of DIAL (an innovative and user-friendly solution based on Multiplatform Voice Assistive Technologies) in reducing unwanted loneliness and increasing the mental health and the quality of life in individuals over 65 years old. Additionally, a secondary objective is to evaluate the experience of using the system, including aspects of usability and satisfaction, and to analyze whether the functionalities provided by DIAL contribute to the improvement of various dimensions in the lives of the elderly. It is hypothesized that DIAL will reduce unwanted loneliness and improve mental health in older people. In addition, we aim to obtain positive ratings in terms of usability and satisfaction with DIAL, along with the verification that most of the functionalities provided by DIAL will be useful to older people.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other University of Valencia trials

Trials by the same sponsor.

NCT07509281 — Peri-implant Tissues Changes for Different Abutment Shapes and Heights · NA · not yet recruiting
NCT07535528 — Implant Placement Depth and Peri-Implant Tissue Outcomes · NA · not yet recruiting
NCT07471555 — Vascular Access and Intraosseus · NA · enrolling by invitation
NCT07463066 — Long-Term Effectiveness of Pain Neuroscience Education in Women With Genito-Pelvic Pain/Penetration Disorder. · not yet recruiting
NCT07419399 — Acute Effects of Radiofrequency Diathermy in Postpartum Women With Diastasis Abdominis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06070402 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valencia
Last refreshed: 6 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06070402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing